tert-Butyl 6-(hydroxymethyl)-2,2-dimethylmorpholine-4-carboxylate

Catalog No. :
ACKERZ082
CAS No. :
1416439-68-3
Molecular Formula :
C12H23NO4
Molecular Weight :
245.32

IUPAC Name:tert-Butyl 6-(hydroxymethyl)-2,2-dimethylmorpholine-4-carboxylate

tert-Butyl 6-(hydroxymethyl)-2,2-dimethylmorpholine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$99.00Login to see priceIn stockIn stock
5g97%$457.00Login to see priceIn stockIn stock
25g97%$1964.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 6-(hydroxymethyl)-2,2-dimethylmorpholine-4-carboxylate
IUPAC Nametert-Butyl 6-(hydroxymethyl)-2,2-dimethylmorpholine-4-carboxylate
MDL No.MFCD22690362
Molecular FormulaC12H23NO4
Molecular Weight245.32
SMILESO=C(N1CC(C)(C)OC(CO)C1)OC(C)(C)C
InChI KeyKKFSVQAEKAPAJT-UHFFFAOYSA-N
SynonymTERT-BUTYL 6-(HYDROXYMETHYL)-2,2-DIMETHYLMORPHOLINE-4-CARBOXYLATE;4-Morpholinecarboxylic acid, 6-(hydroxymethyl)-2,2-dimethyl-, 1,1-dimethylethyl ester;4-Boc-6-(hydroxymethyl)-2,2-dimethylmorpholine
CAS No.1416439-68-3
PubChem CID71742816

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACKERZ082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIBTO673 route compound structure diagram
    ACIBTO6731416439-82-1 In Stock
  4. Then
  5. ACKERZ082 route product structure diagram
    ACKERZ0821416439-68-3 In Stock
Inquiry

2. ACKERZ082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKERZ082 route product structure diagram
    ACKERZ0821416439-68-3 In Stock
Inquiry

Comments (0)